They trust us!

#Partners #Customers #Network

Cevidra is a trusted partner offering integrated continuum for the access to the french market for licensed products & early access products: discover our strong network of customers, partners and contractors.

Our Partners
Our Networks

Our Partners

dne pharma

dne pharma

 

dne pharma, a Norwegian pharmaceutical company established in 1900, specializes in opioid substitution treatment within the Nordic region. They handle product development, registration, manufacturing, and marketing, serving the healthcare needs.

BPL

Bio Products Laboratory is a UK company which has been involved in the manufacturing of blood derivatives for over 60 years. Their products fall into three main therapeutic areas: immunology, critical care and coagulation disorders.

Rosemont

Rosemont is a UK pharmaceutical company based in Leeds. Rosemont has over 50 years’ of experience in the development of oral liquid medicines, both licensed and unlicensed speciality medicines, in a wide range of therapeutic areas.

Rivopharm

Rivopharm is a company based in Switzerland and focused on the development, the manufacturing and the marketing of pharmaceutical products in the field of generics with worldwide markets.

Kedrion

Kedrion is an international Italian company with more than 20 years of experience in the collection and fractionation of blood-derived medicines. Kedrion’s plasma-derived therapies help people suffering from debilitating diseases such as haemophilia and immune deficiencies.

Italfarmaco

Italfarmaco was founded in 1938 in Milan, Italy. The Italfarmaco Group is particularly distinguished by its commitment to clinical research, mainly in the cardiovascular field and diseases associated with immuno-oncological disorders. The expansion of the product portfolio of the entire group and the consolidation on international markets are a priority.

Our Partners

dne pharma

dne pharma

dne pharma, a Norwegian pharmaceutical company established in 1900, specializes in opioid substitution treatment within the Nordic region. They handle product development, registration, manufacturing, and marketing, serving the healthcare needs.

BPL

Bio Products Laboratory is a UK company which has been involved in the manufacturing of blood derivatives for over 60 years. Their products fall into three main therapeutic areas: immunology, critical care and coagulation disorders.

Rosemont

Rosemont is a UK pharmaceutical company based in Leeds. Rosemont has over 50 years’ of experience in the development of oral liquid medicines, both licensed and unlicensed speciality medicines, in a wide range of therapeutic areas.

Rivopharm

Rivopharm is a company based in Switzerland and focused on the development, the manufacturing and the marketing of pharmaceutical products in the field of generics with worldwide markets.

Kedrion

Kedrion is an international Italian company with more than 20 years of experience in the collection and fractionation of blood-derived medicines. Kedrion’s plasma-derived therapies help people suffering from debilitating diseases such as haemophilia and immune deficiencies.

Italfarmaco

Italfarmaco was founded in 1938 in Milan, Italy. The Italfarmaco Group is particularly distinguished by its commitment to clinical research, mainly in the cardiovascular field and diseases associated with immuno-oncological disorders. The expansion of the product portfolio of the entire group and the consolidation on international markets are a priority.

Our Networks

AMLIS

AMLIS is a French company that represents and supports small and medium-sized companies in the healthcare field, on the French territory. AMLIS works very closely with the LEEM and its network which has a strong footprint in the pharmaceutical industry.

EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs is an association representing the interests of the pharmaceutical industry. It was founded in 2008.

Through its members, EUCOPE represents over 2,600 innovative companies that research, design, develop, supply, manufacture and deploy the next generation of pharmaceutical innovations and therapeutic solutions across the European continent.

EUROBIOMED

Eurobiomed is the Competitiveness Cluster of the South of France, dedicated to Healthtech.

Created in 2009 by all the players in the health sector in the South Provence Alpes Côte d’Azur and Occitania regions, Eurobiomed brings together an ecosystem of over 400 industrial players.

Already ranked among the top performing clusters, Eurobiomed has developed innovation engineering and support capacities for companies and territorial projects, making it an important structure for the region and for its industrial and academic players.

MABDESIGN

MabDesign, the French association of the biomedical industry.

Created in 2014, MabDesign aims to structure the biomedical industrial sector in France from its R&D phases through biomanufacturing to market launch and to generate the creation of innovative start-ups from French academic research.

Our Networks

AMLIS

AMLIS is a French company that represents and supports small and medium-sized companies in the healthcare field, on the French territory. AMLIS works very closely with the LEEM and its network which has a strong footprint in the pharmaceutical industry.

EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs is an association representing the interests of the pharmaceutical industry. It was founded in 2008.

Through its members, EUCOPE represents over 2,600 innovative companies that research, design, develop, supply, manufacture and deploy the next generation of pharmaceutical innovations and therapeutic solutions across the European continent.

EUROBIOMED

Eurobiomed is the Competitiveness Cluster of the South of France, dedicated to Healthtech.

Created in 2009 by all the players in the health sector in the South Provence Alpes Côte d’Azur and Occitania regions, Eurobiomed brings together an ecosystem of over 400 industrial players.

Already ranked among the top performing clusters, Eurobiomed has developed innovation engineering and support capacities for companies and territorial projects, making it an important structure for the region and for its industrial and academic players.

MABDESIGN

MabDesign, the French association of the biomedical industry.

Created in 2014, MabDesign aims to structure the biomedical industrial sector in France from its R&D phases through biomanufacturing to market launch and to generate the creation of innovative start-ups from French academic research.